Collection
Advances in pre-clinical cancer models
- Submission status
- Closed
Cancer models are indispensable research tools, as they help elucidating the mechanisms involved in tumour onset and progression, leading to the development of new therapeutic treatments. While widely-used conventional two-dimensional cell models have been the gold standard for many decades, some of their main limitations include the lack of representation of the stromal population, the absence of a three-dimensional structure, and a poor representation of inter-tumour and intra-tumour heterogeneity. Therefore, a multitude of novel cancer models are emerging, which can advance the understanding of tumour pathophysiology and behavior. This will ultimately help improving patients’ clinical outcomes, through the introduction of more personalized and targeted treatments in the clinical setting.
In recognition of the growing field of research, BMC Cancer welcomes submissions to a newly launched collection ‘Advances in pre-clinical cancer models’. Topics of interest for this special issue include but are not limited to:
- Scaffold-based in vitro models
- 3D cell cultures
- Co-culture settings
- Tumour organoids
- Large and small animal models
- Genetically engineered cell lines and animal models
- Chemically induced tumour models
- Xenotransplantation models (Patient derived xenografts, cell-line derived xenograft)
- Allotransplantation models
Articles (9 in this collection)
-
-
Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence
Authors (first, second and last of 5)
- Anais Oudin
- Pilar M. Moreno-Sanchez
- Anna Golebiewska
- Content type: Research
- Open Access
- Published: 02 January 2024
- Article: 3
-
A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models
Authors (first, second and last of 16)
- Ania Naila Guerrieri
- Chiara Bellotti
- Enrico Lucarelli
- Content type: Research
- Open Access
- Published: 06 December 2023
- Article: 1194
-
Hepatocyte-specific HDAC3 ablation promotes hepatocellular carcinoma in females by suppressing Foxa1/2
Authors (first, second and last of 12)
- Yahong Xu
- Yongjie Zhu
- Yujun Shi
- Content type: Research
- Open Access
- Published: 26 September 2023
- Article: 906
-
Impact of media compositions and culture systems on the immunophenotypes of patient-derived breast cancer cells
Authors (first, second and last of 12)
- Seungyeon Ryu
- So-Hyun Yoon
- Wonshik Han
- Content type: Research
- Open Access
- Published: 06 September 2023
- Article: 831
-
Novel human lymph node-derived matrix supports the adhesion of metastatic oral carcinoma cells
Authors (first, second and last of 16)
- Erika Naakka
- Wafa Wahbi
- Tuula Salo
- Content type: Research
- Open Access
- Published: 14 August 2023
- Article: 750
-
Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Authors (first, second and last of 4)
- Swati Chitrangi
- Pooja Vaity
- Shweta Bhatt
- Content type: Research
- Open Access
- Published: 22 July 2023
- Article: 689
-
Advancing preclinical cancer models to assess clinically relevant outcomes
Authors
- Anna Golebiewska
- Ryan C. Fields
- Content type: Editorial
- Open Access
- Published: 10 March 2023
- Article: 230
-
Analysis of connexin 43, connexin 45 and N-cadherin in the human sertoli cell line FS1 and the human seminoma-like cell line TCam-2 in comparison with human testicular biopsies
Authors (first, second and last of 15)
- Birte Schulz
- Valérie Schumacher
- Ralph Brehm
- Content type: Research
- Open Access
- Published: 10 March 2023
- Article: 232